Whitepaper: Pre-IND Meetings Don't overlook this key Opportunity for early FDA Feedback

The first step in the US on your path towards eventual approval is a pre-IND Meeting, which will facilitate communication with the FDA and provide the advantage of early feedback on your development program. This first meeting establishes the tone of your Agency relationship, and as one of the desired outcomes, you want the Agency to gain respect for your company and your science.

DOWNLOAD NOW

By submitting this form, you understand that Cencora may process your data as described in the Cencora Privacy Policy.

First Name

Last Name

Company

Country

State

I agree to the Cencora PharmaLex Privacy Policy**

Please check this box if you wish to receive information from Cencora and its affiliates

Comments

**For more information, please see PharmaLex Privacy Policy.

If you do not wish to receive any communication from us, you may unsubscribe at any time.

This first meeting establishes the tone of your Agency relationship, and as one of the desired outcomes, you want the Agency to gain respect for your company and your science.

Download The free eBook